![Joseph McCracken](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph McCracken
Director/Board Member at
SAVARA INC.
Net worth: 2 M $ as of 2026-06-29
Profile
Joseph S.
McCracken is Director at REGiMMUNE Corp.
since 2015.
Director at Neuropore Therapies, Inc. since 2019.
Director at Modalis Therapeutics Corp.
since 2018.
Lead Independent Director at Savara, Inc. since 2019.
Director at Eos Therapies, Inc. Formerly Director at NewLink Genetics Corp., Aravas, Inc., Calliditas Therapeutics Suisse SA, Calliditas Therapeutics France SAS. Independent Director at Kindred Biosciences, Inc. from 2018 to 2021.
Independent Non-Executive Director at Nexvet Biopharma Plc from 2014 to 2017.
Director at Nexvet Australia Pty Ltd. from 2014 to 2015.
Independent Director at Lumos Pharma, Inc. from 2020 to 2024.
Director at Alkahest, Inc. from 2013 to 2020.
Vice President-Business Development at Genentech, Inc. from 2000 to 2009.
VP, Global Head-Business Development & Licensing at Roche Pharmaceuticals, Inc. from 2011 to 2013.
Vice President-Business Development at Aventis Pharmaceuticals, Inc. VP, Global Head-Business Development & Licensing at Hoffmann-La Roche, Inc. in 2013.
General Manager at Roche Diagnostics KK from 2009 to 2011.
Vice President-Business Development at Rhone-Poulenc Rorer SA from 1997 to 2000.
Education includes undergraduate (1976), graduate (1977), and doctorate (1980) degrees from The Ohio State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SAVARA, INC. 0.13% | 2026-04-05 | 260,837 ( 0.13% ) | 2 M $ | 2026-06-29 |
Joseph McCracken active positions
| Companies | Position | Start |
|---|---|---|
| SAVARA INC. | Director/Board Member | 2013-09-30 |
| MODALIS THERAPEUTICS CORPORATION | Director/Board Member | 2018-07-31 |
Neuropore Therapies, Inc.
 Neuropore Therapies, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics for the treatment parkinson’s disease | Director/Board Member | 2019-10-28 |
REGiMMUNE Corp.
 REGiMMUNE Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops immune medicines | Director/Board Member | 2015-11-30 |
Former positions of Joseph McCracken
| Companies | Position | End |
|---|---|---|
| LUMOS PHARMA, INC. | Director/Board Member | 2024-12-11 |
| KINDRED BIOSCIENCES, INC. | Director/Board Member | 2021-08-26 |
Alkahest, Inc.
 Alkahest, Inc. BiotechnologyHealth Technology Operates as a research and drug discovery company | Director/Board Member | 2020-11-30 |
| NEXVET BIOPHARMA PUBLIC LIMITED CO | Director/Board Member | 2017-07-30 |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Director/Board Member | - |
Training of Joseph McCracken
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Aravas, Inc.
 Aravas, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative drugs for the treatment of serious and life-threatening conditions | Health Technology |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for animals | Health Technology |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Operates as a research and drug discovery company | Health Technology |
Nexvet Biopharma Plc
 Nexvet Biopharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharma company | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Diagnostics KK
 Roche Diagnostics KK Medical SpecialtiesHealth Technology Manufactures and sells medical equipment | Health Technology |
REGiMMUNE Corp.
REGiMMUNE Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops immune medicines | Health Technology |
Rhone-Poulenc Rorer SA | |
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals | Health Technology |
Neuropore Therapies, Inc.
Neuropore Therapies, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics for the treatment parkinson’s disease | Health Technology |
Calliditas Therapeutics France SAS
 Calliditas Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology research and development | Commercial Services |
Savara, Inc.
 Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Modalis Therapeutics Corp.
 Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
- Stock Market
- Insiders
- Joseph McCracken
